Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.12 USD | +0.25% | -0.53% | +58.62% |
24/04 | BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals | MT |
24/04 | BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals | AN |
Sales 2024 * | 103M 8.62B | Sales 2025 * | 207M 17.3B | Capitalization | 1.21B 101B |
---|---|---|---|---|---|
Net income 2024 * | -145M -12.1B | Net income 2025 * | -77M -6.42B | EV / Sales 2024 * | 10.9 x |
Net cash position 2024 * | 82.46M 6.88B | Net cash position 2025 * | 30.63M 2.56B | EV / Sales 2025 * | 5.69 x |
P/E ratio 2024 * |
-7.6
x | P/E ratio 2025 * |
-15
x | Employees | 244 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Tarsus Pharmaceuticals, Inc.
1 day | +0.25% | ||
1 week | -0.53% | ||
Current month | -11.64% | ||
1 month | -11.64% | ||
3 months | +14.80% | ||
6 months | +133.43% | ||
Current year | +58.62% |
Managers | Title | Age | Since |
---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 46 | 01/17/01 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 62 | 24/23/24 |
Sesha Neervannan
COO | Chief Operating Officer | 56 | 16/20/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Link
BRD | Director/Board Member | 78 | 01/17/01 |
Wendy Yarno
BRD | Director/Board Member | 68 | 19/20/19 |
Director/Board Member | 69 | 01/19/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.62% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 32.12 | +0.25% | 429,454 |
26/24/26 | 32.04 | -0.53% | 381,058 |
25/24/25 | 32.21 | -1.68% | 371,846 |
24/24/24 | 32.76 | -2.82% | 317,505 |
23/24/23 | 33.71 | +4.40% | 230,925 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.62% | 1.21B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- TARS Stock